Ignite Creation Date:
2024-05-06 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05109728
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2021-10-27
Brief Title:
A Dose Finding Study of 177LuLu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
October 27 2021
Study First Post Date:
2021-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL